drugset / Trial / NCT03113409
Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study will enroll 30 opioid-dependent participants into an open-label pilot outpatient study of methods to facilitate induction and stabilization onto XR-NTX. There will be three different methods of XR-NTX induction using increasing doses of oral naltrexone and buprenophine.
Timeline
- Start
- 2017-06-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
Outcome
Outcome not reported
Stopped (Business): “no funding available to continue”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |
| Subject | Naltrexone | Small molecule | — | Oral |
| Subject | Naltrexone | Small molecule | — | Intramuscular |